Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for fibromyalgia
IRCT20210306050589N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in fibromyalgia (FM) (3 arms), sponsored by Islamic Azad University. Primary endpoints: Fibromyalgia severity, Pain severity and 2 more. Started Jun 2021; status: completed.
02
Drugs
metformin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on IRCT20210306050589N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210306050589N1.